All posts from Zacks
Zacks in Our Research. Your Success.,

Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards Lifesciences, Orthofix International and INSYS Therapeutics

For Immediate Release

Chicago, IL – July 07, 2017– Today, Zacks Equity Research discusses the Industry: MedTech, Part 1, including Varian Medical Systems, Inc. (NYSE: VAR Free Report ), Inogen, Inc. (NASDAQ: INGN Free Report ), Edwards Lifesciences Corp. (NYSE: EW Free Report ), Orthofix International N.V. (NASDAQ: OFIX Free Report ) and INSYS Therapeutics, Inc. (NASDAQ: INSY Free Report ).

Industry: MedTech, Part 1


There is plenty of uncertainty about the final shape of the Trump administration’s Obamacare ‘repeal & replace’ effort through Congress. But the overall expectation is that the legislative change will result in lower taxes and regulation for the industry as a whole.

To that end, the industry is looking forward to an end to the 2.3% medical device tax. Also, there is a big possibility that the Medical Device fraternity will be exempt from the highly unpopular Cadillac tax (40% excise tax on high-cost healthcare plans).

According to MedTech majors, the abolition of these taxes would directly address issues like lack of opportunity for research and development, innovation, pipeline development and increase investments needed to accelerate patient and provider access to innovative health care products. This will also help in boosting job creation and improving quality of patient care.

However, the latest revelation by some moderate senators to 'keep some of its taxes,' is once again creating quite a stir in the medical device space. Also, the Trump administration has proposed to raise the U.S. Food and Drug Administration (FDA) user fee for medical device in 2018. The U.S. medical device industry mostly consists of small manufacturers that would be substantially affected by higher FDA fees.

Boon or Bane for the Medical Device Community?

Overall, there is a mixed sentiment in the medical device community. The medical device trade association AdvaMed is one of the few that is in favor of the replacement policy. According to AdvaMed, the entire MedTech fraternity is looking forward to new policymakers, who will be working on improving the FDA regulatory process, repeal of the medical device tax, and ensuring that the coverage process gives patients access to the latest innovations.

However, data from CBS discussed above is a dampener. While the White House and Capitol Hill responded to the forecast as ‘just absurd,’ they have yet to justify their stance. This apart, a shrinking customer base indicates an impending slash in the demand for expensive medical procedures and devices. Economists worldwide are divided on this proposal. If it materializes, a major supply/demand disequilibrium within the medical device niche may be created.

Zacks Industry Rank

Within the Zacks Industry classification, Medical Device is broadly grouped into the Medical sector (one of 16 Zacks sectors) and further sub-divided into four industries at the expanded level: Medical - Instruments , Medical - Products , Medical - Dental Supplies and Medical Info Systems .

We rank all the 250-plus industries in the 16 Zacks sectors based on the earnings outlook and fundamental strength of the constituent companies in each. To learn more visit: About Zacks Industry Rank .

The Zacks Industry Rank is #178 (bottom 30% of the 250 plus Zacks classified industries) for Medical - Instruments, #112 (top 44%) for Medical - Products, #99 (top 39%) for Medical - Dental Supplies, #156 (bottom 39%) for Medical Info Systems. Our back-testing shows that the top 50% of the Zacks ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.

Upon analyzing the Zacks Industry Rank for different Medical Device segments, it can be said that the outlook for these aforementioned MedTech subsectors is overall unclear.

Price Performance

The price performances of these Zacks categorized sub industries however indicate a bullish market sentiment.

Year-to-date, while the S&P 500 Market Index has gained 10.4%, the med instruments space has outperformed the trend with a rise of 15.8%. Some of the stocks within this space that have traded above the S&P Index are Varian Medical Systems, Inc. (NYSE: VAR Free Report ), Inogen, Inc. (NASDAQ: INGN Free Report ) and Edwards Lifesciences Corp. (NYSE: EW Free Report ).

Medical Product stocks grew a substantial 20.9% in this period. Some players from this space are ABAX, Orthofix International N.V. (NASDAQ: OFIX Free Report ) and INSYS Therapeutics, Inc. (NASDAQ: INSY Free Report ).

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on VAR - FREE

Get the full Report on INGN - FREE

Get the full Report on EW - FREE

Get the full Report on OFIX - FREE

Get the full Report on INSY - FREE

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Varian Medical Systems, Inc. (VAR): Free Stock Analysis Report
Inogen, Inc (INGN): Free Stock Analysis Report
Edwards Lifesciences Corporation (EW): Free Stock Analysis Report
Orthofix International N.V. (OFIX): Free Stock Analysis Report
Insys Therapeutics, Inc. (INSY): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research